Did you read the recent investor preso? ..From P25: (All of these will impact the share price)
* OA Phase 2b trial results released. Partnering Discussions Commence
* Release Secondary End-point data front the OA Phase 2b trial – Q1/Q2 2019
* Potential to treat to MPS patients in Australia via the SAS – Q1/Q2 CY2019
* Up to 50 ex-NFL players in the US to be treated with iPPS for OA pain
* Potential for significant media attention if treatment is successful – Q1/Q2 CY2019
* File IND for Phase 2/3 for Mucopolysaccharidosis (MPS) - Q2 CY201
* Further release of patients OA data under the TGA special access scheme
throughout 2019
* File TGA Provisional Approval to sell ZILUSOL (iPPS) in Australia
* Q2 CY2019 Ø Ross River Phase 2a (safety study) trial results release – Q2/Q3 CY2019
...to name just a few
The competition and their side effects, page-11
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.5¢ |
Change
0.055(20.4%) |
Mkt cap ! $82.30M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 33.5¢ | 27.5¢ | $1.328M | 4.323M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4624 | 32.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 152597 | 4 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |
